###### Seed capital
# The fertility business is booming 
![image](images/20190810_WBD002_0.jpg) 
> print-edition iconPrint edition | Business | Aug 10th 2019 
BRIGHT-BLUE letters greet women at Trellis, an egg-freezing studio in New York. “It’s up to each of us to invent our own future,” they enjoin. No baby pictures here, of the sort that adorn joyless waiting rooms at traditional fertility clinics. Instead the client-experience manager, Casy Tarnas, invites visitors to grab a charcoal-coloured “fertility-friendly juice”. Turkish-cotton robes await. If this feels like a spa rather than surgery, that is the idea. Egg-freezing, which promises to preserve young women’s healthy eggs until they are ready to start a family, is supposed to be “an empowering experience”. 
The fertility business has always peddled hope to people who struggle to conceive naturally. It still does, extending the promise to singles and same-sex couples as social norms shift, and increasingly—as in the case of Trellis—to the much larger clientele of young women who wish to postpone childbearing while they pursue a career or await “the one”, and are therefore likelier to need help when they do eventually want babies. Data Bridge, a research firm, predicts that by 2026 the global fertility industry could rake in $41bn in sales, from $25bn today. Today one in 60 in America is born thanks to in vitro fertilisation (IVF) and other artificial treatments. In Denmark, Israel and Japan the figure is more than one in 25—and rising. In China revenues could double to over $7bn by 2023, according to Frost & Sullivan, a data firm. Add high operating margins—of around 30% in America for a $20,000 round of IVF—plus the recession-proof nature of the desire for offspring, and investors are understandably excited. 
In 2018 fertility firms received $624m from venture capitalists and private-equity firms, compared with less than $200m in 2009, according to Pitchbook, a data provider. In June Jinxin Fertility raised $360m in an initial public offering, the first on the Hong Kong Stock Exchange for a Chinese fertility firm. The market capitalisation of Vitrolife, a listed Swedish company, has tripled since 2015, to $2bn. 
The money is flowing not just into treating infertility (as IVF clinics do) but also preserving fertility (egg-freezing clinics) and, even further removed from conception, diagnosing if either treatment or preservation might be needed one day (tests and trackers). Of these, infertility treatment is the most mature, though the landscape remains fragmented 41 years after the first IVF baby was born. 
In America and Europe consolidation is now afoot. Private-equity firms think they can cut costs, acquire more patient data and build brands, as they have done with dental clinics. Last month Impilo, a Nordic investment firm which already owned the Fertility Partnership, a big British provider, agreed to buy VivaNeo, which has clinics in Austria, Germany and the Netherlands. China, where between 2006 and 2016 the number of fertility clinics ballooned from 88 to 451, could be next. Everywhere, clinics are bolting on pricey new services, from testing embryos for genetic problems to surgically wounding the womb to encourage the embryo to implant itself. 
The second type of fertility business—preservation—was spawned by more recent breakthroughs in flash-freezing sex cells, which dramatically increased the survival rates of frozen sperm and eggs after thawing. Egg-freezing clinics purport to sidestep a dilemma faced especially by women who wait beyond their mid-thirties, when egg cell deterioration can accelerate, to have a baby. Traditionally such women could improve their chances by buying young, healthy eggs from donors, or accept longer odds with their own eggs. Egg-freezing lets young, healthy women donate to their future selves. 
The procedure mushroomed in America after the American Society for Reproductive Medicine removed the “experimental” label from it in 2012. In 2017 nearly 11,000 American women froze their eggs, 24% more than the previous year, according to the Society for Assisted Reproductive Technology. In Britain the number of frozen-egg cycles doubled between 2013 and 2016, to 1,321. Egg-freezers claim margins similar to IVF; some may already be profitable. 
Although preservation services are mostly aimed at women, firms are also eyeing men. Geneva-based Legacy (“The only life investment you’ll make”) sends a return sperm-collection container by mail, analyses it and, for a hefty premium, stores it in a Swiss nuclear bunker. Since January thousands of men have bought the $99 “Dadi kit” from Dadi, a company in Brooklyn (“Store your sperm, stop the clock”). They include a surprising number of men preparing for a vasectomy, though the average customer is a 31-year-old millennial who has realised that “men too have a biological clock”, says Tom Smith, the founder. 
The babies of the fertility business offer diagnostics. Firms like Everlywell and Modern Fertility send users a kit, costing about $160 apiece, to collect a finger-prick of blood or a drop of spit, which is then analysed for hormonal signs of potential problems. Celmatix, another startup, offers a pricier test to identify genetic markers associated with fertility problems. 
All fertility businesses stir controversy. Last year Pacific, a fertility clinic in San Francisco, and the Cleveland Medical Centre, in Ohio, lost many eggs and embryos to faulty storage. CHA Fertility, in Los Angeles, has been accused of implanting the wrong embryos, which led to the birth mother having to give up twins who were genetically related to two other couples. Peiffer Wolf, an American law firm representing several families involved in similar cases, says the industry, which can face fewer rules in America than nail salons, urgently needs some. 
Clinics in America and beyond are also accused of playing up success. Like motorists and asset managers, most claim above-average results. As for their newfangled extras, the British regulator, which uses a traffic-light system to grade 11 popular IVF add-ons, has yet to give one a green light, meaning it is both safe and effective. The newer breeds of fertility firm are similarly criticised for misleading customers. In fact, existing egg-preservation techniques are expensive, invasive, often ineffective—and regularly oversold. 
In Britain just 41 “ice babies” were born in 2016 using the mother’s own frozen eggs, not nearly enough for reliable statistics, so egg-freezers often cite success rates from defrosted eggs of donors, an unrepresentatively young, healthy sample. Prelude, an American company which recently merged into a bigger venture offering treatment and preservation, promises, improbably, to help families have “as many healthy babies as they want, whenever they want”. Extend Fertility, another American firm, advertises egg-freezing “for the price of a healthy snack”. Celmatix claims that its tests help people “dramatically improve their chances of conceiving”. Modern Fertility concedes it cannot predict the future, but offers a “fertility timeline” that some customers may treat as a bespoke egg timer. Some startups give Instagram influencers subsidised treatments in exchange for touting the service to millennial followers. 
None of which dampens the fertility industry’s appeal to women, men—or investors. Many will be disappointed: prospective parents, because too many of them will still, despite fertility businesses’ promises, be unable to conceive; and, with nothing like the emotional toll, those pouring money into these firms. But the methods—and providers’ prospects—are bound to improve with time. With luck, the capital currently flowing into research on reproduction, a surprisingly mysterious aspect of human biology, will hasten the process. ■ 
<<<<<<< HEAD
-- 
 单词注释:
1.fertility[fә'tiliti]:n. 肥沃, 丰饶, 生产力 [医] 生育力 
2.Aug[]:abbr. 八月（August） 
3.trellis['trelis]:n. 格构, 格子结构, 棚, 架, 棚架式拱道, 格子遮板, 格构遮板, 格构凉亭, 格构拱道 vt. 为...建棚架 [计] 框架, 格式结构 
4.york[jɔ:k]:n. 约克郡；约克王朝 
5.enjoin[in'dʒɒin]:vt. 吩咐, 命令, 嘱咐, 禁止 [法] 责成, 命令, 嘱咐 
6.adorn[ә'dɒ:n]:vt. 装饰, 使生色 
7.joyless['dʒɒilis]:a. 不高兴的, 不快乐的 
8.tarnas[]:[网络] 塔纳斯 
9.grab[græb]:n. 抓握, 掠夺, 强占, 东方沿岸帆船 vi. 抓取, 抢去 vt. 攫取, 捕获, 霸占 
10.spa[spɑ:]:n. 矿泉, 温泉浴场, 矿泉治疗地 [计] 软件出版者协会 
11.empower[im'pauә]:vt. 授予权力, 允许, 使能够 [法] 授权, 准许, 转委 
12.alway['ɔ:lwei]:adv. 永远；总是（等于always） 
13.peddle['pedl]:vi. 挑卖, 沿街叫卖, 游荡, 闲混 vt. 叫卖, 兜售, 散播 
14.conceive[kәn'si:v]:vt. 构思, 认为 vi. 怀孕 
15.norm[nɒ:m]:n. 基准, 模范, 标准, 准则, 平均数 [化] 定额 
16.clientele[.kli:ɒn'tel]:n. 诉讼委托人, 客户 [法] 委托人, 受保护者, 门徒 
17.childbearing['tʃaildbєәriŋ]:n. 分娩 [医] 分娩, 生产 
18.datum['deitәm]:n. 论据, 材料, 资料, 已知数 [医] 材料, 资料, 论据 
19.vitro[]:n. 在试管内 
20.fertilisation[,f\\:tilai'zeiʃən;-li'z-]:n. <主英>=fertilization 
21.ivf[]:abbr. 试管受精（in-vitro fertilization） 
22.Denmark['denmɑ:k]:n. 丹麦 
23.Israel['izreil]:n. 以色列, 以色列后裔, 犹太人 
24.sullivan[]:n. 沙利文, 苏利文（人名） 
25.offspring['ɒ:fspriŋ]:n. 子孙, 后代, 产物 [法] 后辈, 子孙, 后裔 
26.investor[in'vestә]:n. 投资者 [经] 投资者 
27.understandably[]:adv. 可懂, 可了解, 可理解 
28.capitalist['kæpitәlist]:n. 资本家, 资本主义者 a. 资本主义的 
29.les[lei]:abbr. 发射脱离系统（Launch Escape System） 
30.pitchbook[]:[网络] 书；布克 
31.provider[prә'vaidә]:n. 供应者, 供养人, 伙食承办人 [计] 提供器 
32.fertility[fә'tiliti]:n. 肥沃, 丰饶, 生产力 [医] 生育力 
33.hong[hɔŋ]:n. （中国、日本的）行, 商行 
34.kong[kɔŋ]:n. 含锡砾石下的无矿基岩；钢 
35.capitalisation[,kæpitәlai'zeiʃən;-li'z-]:n. <主英>=capitalization 
36.Swedish['swi:diʃ]:n. 瑞典人, 瑞典语 a. 瑞典的, 瑞典人的, 瑞典语的 
37.triple['tripl]:n. 三倍数, 三个一组 a. 三倍的 vt. 使增至三倍 vi. 增至三倍 
38.infertility[.infә'tiliti]:n. 不肥沃, 不毛 [医] 不育症, 不孕症 
39.conception[kɒn'sepʃәn]:n. 观念, 概念 [医] 妊娠, 受孕; 概念 
40.diagnose['daiәgnәuz]:v. 诊断 
41.preservation[.prezә'veiʃәn]:n. 保存, 保藏, 保护 [医] 保藏, 保存, 防腐 
42.tracker['trækә]:n. 追踪者, 跟踪雷达, 拉纤者 [法] 追踪人, 探索者, 追踪空中移动物体的仪器 
43.landscape['lændskeip]:n. 风景, 山水, 风景画 vi. 从事景观美化 vt. 美化...景观 [计] 横向 
44.consolidation[kәn.sɒli'deiʃәn]:n. 巩固, 团结, 合并, 加强 [医] 实变 
45.afoot[ә'fut]:a. 徒步的, 在进行中的, 活动中的 adv. 徒步, 在进行中 
46.dental['dentl]:a. 牙齿的 [医] 牙的, 齿的, 齿音, 齿音字母 
47.Nordic['nɒ:dik]:n. 北欧人, 日耳曼民族, 北欧两项滑雪 a. 北欧人的, 日耳曼民族的, 北欧两项滑雪的 
48.partnership['pɑ:tnәʃip]:n. 合伙, 合股, 合作关系 [经] 合伙(合作)关系, 全体合伙人 
49.Austria['ɒstriә]:n. 奥地利 
50.Netherlands['neðәlәndz]:n. 荷兰 
51.pricey['praisi]:a. 昂贵的, 价格高的 
52.embryo['embriәu]:n. 胚胎, 胎儿, 胚芽 [医] 胚, 胚胎 
53.surgically[]:adv. 如外科手术般地 
54.womb[wu:m]:n. 子宫, 发源地 [医] 子宫 
55.implant[im'plɑ:nt]:vt. 深植, 灌输, 嵌入 n. 植入物, 植入管 
56.spawn[spɒ:n]:n. (鱼)卵, 产物 vt. 产卵, 酿成, 大量生产 vi. 产卵, 大量生产 
57.dramatically[drә'mætikli]:adv. 戏剧地, 引人注目地, 突然地 
58.sperm[spә:m]:n. 精液, 精虫, 鲸油, 抹香鲸 [化] 鲸蜡油 
59.thaw[θɒ:]:n. 融解, 融化, 解冻时期 vt. 使融解, 使缓和 vi. 融化, 解冻 
60.purport['pә:pɒ:t]:n. 意义, 要旨, 目的 vt. 意味着, 声称, 打算 
61.sidestep['saidstep]:n. 横跨的一步, 台阶 vt. 横跨一步躲避, 回避 vi. 回避问题, 躲避打击 
62.deterioration[di.tiәriә'reiʃәn]:n. 恶化, 衰退, 退化 [医] 变坏, 变质, 颓废, 衰退 
63.traditionally[]:adv. 传统上；传说上；习惯上 
64.donor['dәunә]:n. 捐赠人 [化] 给体; 供体 
65.odds[ɒdz]:n. 可能性, 几率, 机会, 胜算, 不平等 
66.donate['dәuneit]:v. 捐赠 
67.reproductive[.ri:prә'dʌktiv]:a. 生殖的, 再生的, 复制的 [医] 生殖的, 复现的 
68.legacy['legәsi]:n. 祖先传下来之物, 遗赠物 [经] 遗产, 遗赠物 
69.hefty['hefti]:a. 重的, 肌肉发达的 
70.premium['pri:miәm]:n. 额外补贴, 奖金, 奖赏, 保险费 [医] 保险费 
71.bunker['bʌŋkә]:n. 煤仓, 沙坑, 暗堡 vt. 击入沙坑, 使陷入困境 
72.dadi[]:n. (Dadi)人名；(匈)道迪；(尼日尔、乍、意)达迪 abbr. 二甲氧基苯胺二异氰酸酯（dianisidine diisocyanate） 
73.kit[kit]:n. 装备, 工具箱, 成套工具 [计] 成套部件; 成套零件 
74.Brooklyn['bruklin]:n. 布鲁克林区(纽约行政区) 
75.vasectomy[væ'sektәmi]:n. 输精管切除术 [医] 输精管切除术 
76.millennial[mi'leniәl]:a. 一千年的, 千福年的 
77.biological[.baiәu'lɒdʒikәl]:a. 生物学的 [医] 生物学的 
78.tom[tɒm]:n. 雄性动物, 雄猫 
79.smith[smiθ]:n. 铁匠, 金属品工匠 [机] 锻造工, 上手 
80.founder['faundә]:n. 创立者, 建立者 vt. 使沉没, 使摔倒, 弄跛, 浸水, 破坏 vi. 沉没, 摔到, 变跛, 倒塌, 失败 
81.diagnostics[,daiә^'nɔstiks]:n. 诊断学, 症候, 症状 [医] 诊断学 
82.apiece[ә'pi:s]:adv. 就每个而论, 各 
83.hormonal[hɒ:'mәunәl]:a. 荷尔蒙的 [医] 激素的 
84.startup[]:[计] 启动 
85.pricy['praisi]:a. 昂贵的, 价格高的 
86.marker['mɑ:kә]:n. 作记号的人, 记分员, 书签, 纪念碑, 里程碑, 标识物, 标记 [计] 标记 
87.controversy['kɒntrәvә:si]:n. 论争, 辩论, 论战, 争论 [法] 论战, 争论, 争吵 
88.san[sɑ:n]:abbr. 存储区域网（Storage Area Networking） 
89.francisco[fræn'siskәu]:n. 弗朗西斯科（男子名, 等于Francis） 
90.Cleveland['kli:vlәnd]:n. 克利夫兰 
91.Ohio[әu'haiәu]:n. 俄亥俄 
92.cha[tʃɑ:]:n. （英俚）茶 
93.los[lɔ:s]:abbr. 月球轨道航天器（Lunar Orbiter Spacecraft）；视线（Line of Sight） 
94.angeles[]:n. 安杰利斯（姓氏）；天使城（菲律宾地名） 
95.genetically[]:adv. 创始, 遗传学, 生殖, 基因, 遗传, 发生 
96.peiffer[]: [人名] 派弗 
97.salon['sælɔ:ŋ]:n. 大会客室, 大厅, 客厅, 交谊室, 沙龙, 美术展览馆, 画廊, 美容院, 发廊 
98.urgently[]:adv. 急切地；迫切地；紧急地 
99.motorist['mәutәrist]:n. 开汽车者, 驾车旅行的人 
100.asset['æset]:n. 资产, 有益的东西 
101.newfangled['nju:fæŋgld]:a. 新奇的, 最新式的, 最新流行的 
102.regulator['regjuleitә]:n. 调整者, 校准者, 校准器, 调整器, 标准钟 [化] 调节剂; 调节器 
103.criticise['kritisaiz]:v. 批评, 吹毛求疵, 非难 
104.misleading[mis'li:diŋ]:a. 引入歧途的, 使人误解的, 骗人的 [法] 误写姓名的, 误称的, 令人误解的 
105.invasive[in'veisiv]:a. 侵入的, 侵略性的, 攻击性的 
106.oversell[.әuvә'sel]:vt. 销售过多, 卖空, 过分吹嘘 vi. 卖空, 吹嘘过分 
107.statistic[stә'tistik]:n. 统计量 a. 统计的, 统计学的 
108.cite[sait]:vt. 引用, 引证, 表彰 [建] 引证, 指引 
109.defrost[.di:'frɒst]:vt. 除霜 vi. 解冻 
110.prelude['prelju:d]:n. 前奏, 序幕, 序诗, 前奏曲 vi. 作为前奏 vt. 作为...的开头 
111.merge[mә:dʒ]:vt. 使合并, 使消失, 吞没 vi. 合并, 渐渐消失 [计] 合并 
112.improbably[im'prɒbәbli]:adv. 未必会地, 不象真实地 
113.concede[kәn'si:d]:vt. 承认, 退让 vi. 让步 
114.cannot['kænɒt]:aux. 无法, 不能 
115.timeline[ˈtaɪmlaɪn]:n. 时间轴, 时间表 
116.bespeak[bi'spi:k]:vt. 预约, 订, 表示 n. 预约 
117.timer['taimә]:n. 计时员, 计时器 [计] 计时器 
118.Instagram[]:一款图片分享应用 
119.influencer[]:n. 影响者 
120.subsidise[]:vt. 给...补助金, 津贴, 资助 
121.tout[taut]:vi. 招徕顾客, 兜售物品 vt. 招徕, 刺探...情报 n. 兜售者, 侦查者 
122.follower['fɒlәuә]:n. 从者, 属下, 追补者 [电] 随动机 
123.dampen['dæmpәn]:vt. 弄湿, 使沮丧 vi. 变湿, 丧气 
124.prospective[prәs'pektiv]:a. 预期的, 将来的 [经] 预期的, 未来的 
125.toll[tәul]:n. 通行费, 代价, 钟声 vt. 征收, 敲钟, 鸣钟, 勾引, 引诱 vi. 征税, 鸣钟 
126.currently['kʌrәntli]:adv. 现在, 当前, 一般, 普通 [计] 当前 
127.reproduction[.ri:prә'dʌkʃәn]:n. 再现, 复制, 生殖, 繁殖, 复制品 [医] 生殖, 复现(心理) 
=======
>>>>>>> 50f1fbac684ef65c788c2c3b1cb359dd2a904378
